NASDAQ:REPL

Replimune Group Stock Insider Trading

etoro logo Buy REPL
*Your capital is at risk
$9.98
+1.11 (+12.51%)
At Close: Jun 03, 2026

Replimune Group Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.82. In total, the insiders bought 29.84M and sold 318.58K REPL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
91.82
Buy 29.84M shares
Sell 318.58K shares
74% Buy Activity
Moderate Negative Correlation
Sell Signal Low Confidence
May 18, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 91.82.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Apr 01, 2026
Buy
Stock Option (right to buy)
A-Award
Peeples-dyer Veleka
Director
Director 44 500
Value: $338.6K
Apr 01, 2026
Buy
Common Stock
A-Award
Hill Emily Luisa
Chief Financial Officer
C-Suite Officer 50 000
Value: $380.5K
Feb 18, 2026
Sell
Common Stock
G-Gift
Astley-sparke Philip
Director
Director 25 000
Value: $0
Dec 19, 2025
Buy
Common Stock
A-Award
Patel Sushil
Chief Executive Officer
CEO / President 200 000
Value: $1.98M
Dec 19, 2025
Buy
Common Stock
A-Award
Xynos Konstantinos
Chief Medical Officer
Officer 60 000
Value: $592.8K
Dec 19, 2025
Buy
Common Stock
A-Award
Hill Emily Luisa
Chief Financial Officer
C-Suite Officer 60 000
Value: $592.8K
Dec 19, 2025
Buy
Common Stock
A-Award
Sarchi Christopher
Chief Commercial Officer
Officer 35 000
Value: $345.8K
Dec 19, 2025
Buy
Common Stock
A-Award
Schwendenman Andrew
Chief Accounting Officer
Officer 10 000
Value: $98.8K
Dec 09, 2025
Buy
Common Stock
M-Exempt
Dhingra Kapil
Director
Director 3 169
Value: $6K
Dec 09, 2025
Sell
Common Stock
S-Sale
Dhingra Kapil
Director
Director 3 169
Value: $33.0K
Dec 09, 2025
Buy
Stock Option (right to buy)
M-Exempt
Dhingra Kapil
Director
Director 3 169
Value: $6K
Dec 02, 2025
Sell
Common Stock
S-Sale
Patel Sushil
Chief Executive Officer
CEO / President 10 000
Value: $111.3K
Nov 17, 2025
Sell
Common Stock
S-Sale
Xynos Konstantinos
Chief Medical Officer
Officer 7 248
Value: $66.0K
Nov 17, 2025
Sell
Common Stock
S-Sale
Sarchi Christopher
Chief Commercial Officer
Officer 5 208
Value: $47.4K
Aug 15, 2025
Sell
Common Stock
S-Sale
Hill Emily Luisa
Chief Financial Officer
C-Suite Officer 9 154
Value: $49.2K
Aug 15, 2025
Sell
Common Stock
S-Sale
Hill Emily Luisa
Chief Financial Officer
C-Suite Officer 9 154
Value: $49.2K
May 20, 2025
Sell
Common Stock
S-Sale
Astley-sparke Philip
Director
Director 32 279
Value: $260.2K
May 20, 2025
Sell
Common Stock
S-Sale
Xynos Konstantinos
Chief Medical Officer
Officer 7 952
Value: $64.1K
May 20, 2025
Sell
Common Stock
S-Sale
Schwendenman Andrew
Chief Accounting Officer
Officer 3 287
Value: $26.5K
May 20, 2025
Sell
Common Stock
S-Sale
Patel Sushil
Chief Executive Officer
CEO / President 25 105
Value: $202.3K
May 20, 2025
Sell
Common Stock
S-Sale
Hill Emily Luisa
Chief Financial Officer
C-Suite Officer 2 535
Value: $20.4K
May 20, 2025
Sell
Common Stock
S-Sale
Sarchi Christopher
Chief Commercial Officer
Officer 3 749
Value: $30.2K
May 20, 2025
Sell
Common Stock
S-Sale
Sarchi Christopher
Chief Commercial Officer
Officer 3 749
Value: $30.2K
May 20, 2025
Sell
Common Stock
S-Sale
Hill Emily Luisa
Chief Financial Officer
C-Suite Officer 2 535
Value: $20.4K
May 20, 2025
Sell
Common Stock
S-Sale
Patel Sushil
Chief Executive Officer
CEO / President 25 105
Value: $202.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT REPLIMUNE GROUP INC.
Replimune Group
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Pha...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE